Clinical Trial Update: Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

The document reports an ongoing Phase 1/Phase 2 clinical trial evaluating tegavivint in metastatic colorectal cancer, including patients with APC or CTNNB1 muta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Tegavivint

Snippet

Sponsor: HonorHealth Research Institute | Conditions: Metastatic Colorectal Carcinoma (mCRC), Colorectal Cancer (CRC) | Phase 1, Phase 2 | Status: RECRUITING